Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy r...
Gespeichert in:
| Veröffentlicht in: | Journal of thrombosis and haemostasis Jg. 18; H. 5; S. 1094 - 1099 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Elsevier Limited
01.05.2020
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc |
| Schlagworte: | |
| ISSN: | 1538-7933, 1538-7836, 1538-7836 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!